硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 LIMA1 抗体对
试剂盒

抗人 LIMA1 抗体对

01AB01511

LIM domain and actin binding 1 (LIMA1), also known as EPLIN or SREBP3, is a cytoskeleton-associated protein that plays a crucial role in regulating actin filament dynamics. It contains a central LIM domain and multiple actin-binding domains at its ends, enabling it to cross-link and stabilize actin filaments, increase the number and size of actin stress fibers, and inhibit actin filament depolymerization and membrane ruffling. LIMA1 exists in two isoforms, LIMA1-α and LIMA1-β, and can dimerize or interact with other proteins via its LIM domain. By stabilizing the actin network and inhibiting Arp2/3-mediated actin nucleation, LIMA1 is essential for maintaining cytoskeletal integrity and cadherin-mediated cell adhesion. Loss or deficiency of LIMA1 disrupts cytoskeletal dynamics, cell motility, and cell-cell adhesion, which can enhance tumor cell proliferation, invasion, and migration.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
LIMA1
基因别名
EPLIN; SREBP3
蛋白别名
LIM domain and actin binding 1; LIMA1
UniProt
Q9UHB6
物种
Human

产品详情

靶点名称
LIMA1
蛋白名称
LIM domain and actin binding 1
蛋白别名
LIM domain and actin-binding protein 1; Epithelial protein lost in neoplasm
靶点基因名
LIMA1
基因别名
EPLIN; SREBP3
UniProt
Q9UHB6
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

LIM domain and actin binding 1 (LIMA1), also known as EPLIN or SREBP3, is a cytoskeleton-associated protein that plays a crucial role in regulating actin filament dynamics. It contains a central LIM domain and multiple actin-binding domains at its ends, enabling it to cross-link and stabilize actin filaments, increase the number and size of actin stress fibers, and inhibit actin filament depolymerization and membrane ruffling. LIMA1 exists in two isoforms, LIMA1-α and LIMA1-β, and can dimerize or interact with other proteins via its LIM domain. By stabilizing the actin network and inhibiting Arp2/3-mediated actin nucleation, LIMA1 is essential for maintaining cytoskeletal integrity and cadherin-mediated cell adhesion. Loss or deficiency of LIMA1 disrupts cytoskeletal dynamics, cell motility, and cell-cell adhesion, which can enhance tumor cell proliferation, invasion, and migration.